Human studies link coronary artery disease with biological-age acceleration, lipid and inflammatory markers, and polygenic risk. Human trial reports describe lower coronary disease risk with omega-3 fatty acids, while a screening trial shows no clear effect. In a study of adults with congenital heart disease, coronary disease is associated with higher mortality.
1,211 findings in 876 papers from 1990 to 2026, 231 of them since April 2026
“there was 1.21% absolute CHD risk reduction in the top tertile of the expected benefit, compared with the average effect of 0.47% risk reduction.”
Hormone replacement therapy showed no clear effect on coronary artery disease in humans (history of treated hyperlipidemia or untreated with favorable lipid profiles).
“Randomization to oral MHT did not increase CHD risk in participants with a history of treated hyperlipidemia or in untreated participants with favorable lipid profiles”
Human trialhistory of treated hyperlipidemia or untreated with favorable lipid profilesoralfemales
Hormone replacement therapy protects against coronary artery disease in humans (started early after menopause (timing hypothesis)).
“Recent evidence supports the cardioprotective effects of HRT when started early after menopause, ideally within ten years or before the age of sixty, in line with the "timing hypothesis".”
Reviewstarted early after menopause (timing hypothesis)
Systematic screening showed no clear effect on coronary artery disease in humans (pooled HR/RR 0.76; 95% CI 0.48–1.19).
“Screening did not significantly reduce major cardiovascular outcomes in the four trials included in the quantitative synthesis (pooled HR/RR 0.76; 95% CI 0.48–1.19).”
Systematic screening showed no clear effect on coronary artery disease in asymptomatic adults with diabetes and no known CAD (pooled HR/RR 0.76; 95% CI 0.48-1.19).
“Screening did not significantly reduce major cardiovascular outcomes in the four trials included in the quantitative synthesis (pooled HR/RR 0.76; 95% CI 0.48-1.19).”
Human trialin asymptomatic adults with diabetes and no known CADn = 3,315
Sleep duration was not clearly linked with coronary artery disease in humans (Short sleep duration with excellent sleep quality) (PR 0.94, 95% CI 0.79-1.11; p=0.47).
“short sleep duration with excellent quality was not associated with higher CHD prevalence (PR 0.94, 95% CI 0.79-1.11; p=0.47)”
HumansShort sleep duration with excellent sleep quality
Conjugated equine estrogens + medroxyprogesterone acetate showed no clear effect on coronary artery disease in humans (normal low-density lipoprotein (LDL) cholesterol levels (less than 130 mg/dL)) (HR 0.59; 95% CI, 0.31-1.10).
“the CHD risk in untreated participants with normal low-density lipoprotein (LDL) cholesterol levels (less than 130 mg/dL) was similar to that of placebo-treated participants (hazard ratio [HR] 0.59; 95% CI, 0.31-1.10)”
Human trialnormal low-density lipoprotein (LDL) cholesterol levels (less than 130 mg/dL)oral0.625 mg/d CEE + 2.5 mg/d MPAfemales
Lipoprotein is linked with higher coronary artery disease in humans (direct causal effect independent of LDL-C, network deconvolution Mendelian randomization) (OR 1.36 (95% CI 1.21-1.54)).
“independent of low-density lipoprotein cholesterol, on coronary artery disease (OR: 1.36; 95% CI: 1.21-1.54)”
Coronary artery disease is linked with higher IL-6 in humans.
“Across the CAD spectrum, a stepwise increase in systemic IL-6, TNF-α, MCP-1, ICAM-1, and VCAM-1 were observed, reaching peak levels during acute STEMI.”
Humansstepwise rise from healthy subjects through stable CAD to acute STEMI; MCP-1, ICAM-1 and VCAM-1 rose similarly
Coronary artery disease is linked with worse digits Forward performance in humans (multivariable linear regression adjusted for age, sex, and HIV status) (b = 0.386; 95% CI, 0.028 to 0.744; P = 0.035; q = 0.210).
“nominally associated with poorer performance on Digits Forward (a measure of attention and immediate verbal span) (b = 0.386; 95% CI, 0.028 to 0.744; P = 0.035; q = 0.210).”
Humansmultivariable linear regression adjusted for age, sex, and HIV statusn = 512
Coronary artery disease is linked with worse color Trails 2 performance in humans (multivariable linear regression adjusted for age, sex, and HIV status) (b = 0.502; 95% CI, 0.184 to 0.821; P = 0.002; q = 0.026).
“CAD was associated with poorer performance on Color Trails 2 (a measure of executive function) (b = 0.502; 95% CI, 0.184 to 0.821; P = 0.002; q = 0.026)”
Humansmultivariable linear regression adjusted for age, sex, and HIV statusn = 512
Coronary artery disease was not clearly linked with global cognition in humans (multivariable linear regression adjusted for age, sex, and HIV status) (b = 0.093 SD units; 95% CI, - 0.122 to 0.308; P = 0.397).
“CAD was not associated with global cognition (b = 0.093 SD units; 95% CI, - 0.122 to 0.308; P = 0.397).”
Humansmultivariable linear regression adjusted for age, sex, and HIV statusn = 512
“Conversely, CAD-related stressors, including atherosclerotic injury, disturbed flow, myocardial ischaemia and ischaemia-reperfusion injury, can induce local senescence programmes”
Coronary artery disease mediates frailty in silico (two-step MR analysis of leisure screen time and frailty) (accounting for 7.2% of the total effect).
“BMI, HTN, CAD, and T2D showed separate, modest mediation signals, accounting for 11.4%, 12.7%, 7.2%, and 7.8% of the total effect, respectively.”
In silicotwo-step MR analysis of leisure screen time and frailty
Coronary artery disease is linked with lower length of stay in humans (acute pulmonary edema) (OR 0.52; 95% CI: 0.28-0.98; P = .042).
“The history of coronary artery disease was independently associated with lower odds of prolonged hospitalization (OR 0.52; 95% CI: 0.28-0.98; P = .042).”
Coronary artery disease is linked with higher iron in humans (specifically in watershed regions).
“the coronary artery disease group showed lower myelin and higher iron content, as measured by lower MTsat and R1, and higher susceptibility specifically in watershed regions”
Humansspecifically in watershed regionsnormal-appearing white matter
Apolipoprotein B was not clearly linked with coronary artery disease in humans among participants with CAC 0, compared with CAC 0 and normal ApoB (HR 1.15 (95% CI 0.59–2.23) for CAC 0 with high ApoB versus CAC 0 with normal ApoB).
“Compared to group 1 (CAC 0 with normal ApoB), CAC 0 and high ApoB (group 2) was not associated with increased risk of CHD”
Humansamong participants with CAC 0, compared with CAC 0 and normal ApoBmedian follow-up 13.9 years
Lipoprotein was not clearly linked with coronary artery disease in humans (Lebanese adult tertiary-care cohort).
“Logistic regression analysis showed no significant association between Lp(a) levels and cardiovascular factors including dyslipidemia, hypertension, coronary artery disease, previous coronary artery bypass graft, and previous myocardial infarction.”
Lipoprotein was not clearly linked with coronary artery disease in humans (elevated Lp(a) without MetS compared to normal Lp(a) without MetS) (HR: 1.30; 95% CI: 0.94, 1.80).
“those with elevated Lp(a) without MetS (group 2) did not have increased risk of CHD (HR: 1.30; 95% CI: 0.94, 1.80).”
Humanselevated Lp(a) without MetS compared to normal Lp(a) without MetS
Estimated glomerular filtration rate is linked with coronary artery disease in humans (Mediation of the association between APOL1 high-risk genotype and coronary artery disease) (27.7% mediated).
“Baseline eGFR was the only consistent mediator, with a greater proportion mediated for coronary phenotypes, including CAD (27.7%) and myocardial infarction (26.5%)”
HumansMediation of the association between APOL1 high-risk genotype and coronary artery diseasen = 3,303
Insomnia is linked with coronary artery disease in humans (partial mediation of the predisposing effect of veillonella unclassified) (5.7% mediated).
“insomnia partially mediated the causal, predisposing effect of species Veillonella unclassified on increased CAD risk, with a proportion mediated of 5.7%.”
Humanspartial mediation of the predisposing effect of veillonella unclassified
Menopausal timing was not clearly linked with coronary artery disease in humans (genetically determined) (OR 0.97, 95% CI 0.87-1.07).
“genetically determined menopausal timing was not significantly associated with the risk of coronary heart disease (OR = 0.97; 95% CI, 0.87-1.07; P = 0.52”
Lipoprotein is linked with a higher risk of coronary artery disease in humans (Inverse-variance weighted Mendelian randomization) (IVW OR 1.15, 95% CI 1.13–1.17).
“Mendelian randomization confirmed causal effects on PAD (IVW OR=1.05, 95% CI 1.04-1.07) and CAD (IVW OR=1.15, 95% CI 1.13-1.17)”
Lipoprotein is associated with coronary artery disease in humans (Hypercholesterolemia; elevated lipoprotein(a) versus non-elevated lipoprotein(a)) (7.4% vs 6.1%; HR 1.20, 95% CI 1.10–1.32).
“new coronary artery disease (7.4% vs 6.1%; RR 1.21, 95% CI 1.10-1.32; HR 1.20, 95% CI 1.10-1.32; P<0.001)”
HumansHypercholesterolemia; elevated lipoprotein(a) versus non-elevated lipoprotein(a)1,095 daysn = 15,925
Lipoprotein is associated with coronary artery disease in humans (history of coronary artery disease).
“Elevated Lp(a) was associated with a history of coronary artery disease (p-trend=0.003) and with treatment with high-intensity statins alone (p-trend=0.032) or in combination with ezetimibe (p-trend=0.014).”
Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·
Lipoprotein is linked with a higher risk of coronary artery disease in humans (biomarker elevation) (HR 1.20 (95% CI: 1.12-1.29)).
Polygenic risk score is associated with coronary artery disease in humans (Q4 versus Q1 polygenic risk score; association attenuated with age) (Q4-vs-Q1 HR 7.1 at age 45 and 2.5 at age 70; -0.18/yr).
“For CAD, the observed Q4-vs-Q1 PRS hazard ratio fell from 7.1 at age 45 to 2.5 at age 70 (-0.18/yr);”
HumansQ4 versus Q1 polygenic risk score; association attenuated with age
Polygenic risk score predicts coronary artery disease in individuals with chronic kidney disease, accounting for PREVENT risk factors.
“A PRS of CHD was significantly associated with a 21% hazard of CHD in the PRS+PREVENT risk model (95% CI, [1.06-1.39], 2-sided Wald test P =5.5×10 -3 ).”
Humansin individuals with chronic kidney disease, accounting for PREVENT risk factors10-year
Polygenic risk score is associated with coronary artery disease in humans (Adjusted subdistribution HR 1.37 per 1 SD; 95% CI 1.21–1.55).
“Each 1-SD increase in the principal component-adjusted PRS was associated with the primary endpoint (adjusted subdistribution hazard ratio, 1.37; 95% CI, 1.21-1.55; p < 0.001).”
HumansWithout baseline coronary artery disease; per 1-SD increase in principal component-adjusted polygenic risk scoreMedian follow-up of 6.8 yearsn = 2,067
Polygenic risk score predicts coronary artery disease in humans (combined with age and sex) (AUC 0.910).
“the PRS models demonstrated strong predictive performance for coronary artery disease, atherosclerosis, and ischemic stroke, with area under the curve values of 0.910, 0.926, and 0.854, respectively.”
Polygenic risk score is associated with coronary artery disease in humans (nonobstructive CAD on coronary angiography) (OR 1.26, 95% CI 1.14-1.39).
“increasing levels of the polygenic risk score were strongly associated with increased prevalence of nonobstructive and obstructive CAD on coronary angiography (odds ratio, 1.26 [95% CI, 1.14-1.39]”
Polygenic risk score is linked with a higher risk of coronary artery disease in humans (positive family history and high polygenic risk score) (OR: 3.26; 95% CI: 3.03 - 3.50).
Coronary artery disease is linked with a higher risk of mortality in humans (multivariable Cox regression in patients under best medical therapy) (HR 2.0, 95% CI 1.3-3.0).
Mortality is associated with coronary artery disease in humans (concurrent aortic stenosis and coronary artery disease in males vs females) (26.32 vs. 12.15 in 2024).
“Males had higher AAMRs than females (26.32 vs. 12.15 in 2024).”
Humansconcurrent aortic stenosis and coronary artery disease in males vs females2024males
Coronary artery disease is linked with a higher risk of mortality in humans.
“In multivariable Cox models, age and coronary artery disease were consistently associated with higher all-cause mortality across all model specifications.”
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae·
Coronary artery disease is linked with a higher risk of mortality in humans (acute stroke treated with reperfusion therapies) (OR = 8.02, 95% CI: 1.66-38.68).
Clonal hematopoiesis of indeterminate potential raises the risk of coronary artery disease in humans.
“Clinical cohort data link CHIP to increased risk of coronary heart disease, early-onset myocardial infarction, and mortality following transcatheter aortic valve implantation.”
Clonal hematopoiesis of indeterminate potential raises the risk of coronary artery disease.
“Epidemiological studies consistently demonstrate that CH is independently associated with increased risks of coronary artery disease, heart failure, aortic stenosis, and cardiovascular mortality.”
Coronary artery disease is associated with frailty in humans (regression analysis in patients on hemodialysis).
“Regression analysis demonstrated that heart failure, cancer, and coronary artery disease/ischemic heart disease were significantly associated with frailty.”
Humansregression analysis in patients on hemodialysis
Frailty is associated with coronary artery disease in humans (p=0.01).
“Participants categorised as prefrail or frail had higher body mass index (p=0.031) and more frequently presented with coronary artery disease (p=0.01) and multimorbidity (p=0.027) compared with robust individuals.”
Coronary artery disease is linked with a higher risk of frailty in humans.
“Independent risk factors for frailty included age, coronary artery disease (CAD), old cerebral infarction (OCI), neutrophil, neutrophil to lymphocyte rate (NLR), high-sensitivity C-reactive protein (hs-CRP), albumin, fibrinogen to albumin ratio (FAR) and erythrocyte sedimentation rate (ESR).”
Hypertension is associated with coronary artery disease in homozygous familial hypercholesterolemia after propensity score matching (OR 1.85; 95%CI 1.11-3.08, p = 0.02).
“hypertension was significantly associated with CAD (OR 1.85; 95%CI 1.11-3.08, p = 0.02)”
Humansin homozygous familial hypercholesterolemia after propensity score matching
Hypertension is linked with a higher risk of coronary artery disease in humans (men of Japanese ancestry, adjusted for age and cardiovascular risk factors) (HR 1.61; 95% CI 1.44-1.80).
“in men of Japanese ancestry, hypertension was a strong predictor of CAD (hazard ratio [HR] 1.61; 95% confidence interval [CI] 1.44-1.80)”
Humansmen of Japanese ancestry, adjusted for age and cardiovascular risk factorsmalesn = 5,415
The journals of gerontology. Series A, Biological sciences and medical sciences·
Hypertension is associated with coronary artery disease in humans.
“Higher prevalence rates were observed among older individuals, urban residents, those with higher education levels, males, and participants with hypertension, diabetes, and elevated total cholesterol levels.”
Triglyceride-glucose index is associated with coronary artery disease in humans (postmenopausal women) (HR 1.74, 95% CI 1.52–1.99 per 1-unit increase).
“CHD: HR = 1.74, 95 % CI: 1.52, 1.99;”
Humanspostmenopausal women1-unit increaseup to 32 yearsfemalesn = 11,769
Triglyceride-glucose index is linked with a higher risk of coronary artery disease in humans (highest TyG quartile (Q4) vs lowest quartile) (OR = 2.11, 95% CI: 1.51-2.89).
“the highest TyG quartile (Q4) in China showed a 2.11-fold increased CHD risk (95% CI: 1.51-2.89)”
Humanshighest TyG quartile (Q4) vs lowest quartile
Physical activity is associated with coronary artery disease in humans (20% lower CHD risk; HR 0.8).
“A 20% lower CHD risk (hazard ratio [HR], 0.8) was observed at approximately 60 minutes per week of moderate‐to‐vigorous physical activity in older adults”
HumansModerate-to-vigorous physical activityApproximately 60 minutes per weekMedian follow-up of 7.88 yearsn = 31,663
Physical activity is associated with coronary artery disease in humans (UK Biobank) (Active: HR 0.92, 95% CI 0.88–0.96; highly active: HR 0.89, 95% CI 0.86–0.92).
“CHD events (active: HR 0.92; 95% CI, 0.88–0.96; highly active: HR 0.89; 95% CI, 0.86–0.92; P for trend < 0.001)”
Physical activity is linked with a lower risk of coronary artery disease in humans after correcting for regression dilution (20% lower risk of CHD per usual 4000 steps).
“the inverse association between daily step count and CHD showed a 20% lower risk of CHD per usual 4000 steps after correcting for regression dilution compared with 13% before correction”
Humansafter correcting for regression dilutionper usual 4000 stepsn = 87,038
Low-density lipoprotein cholesterol is linked with a higher risk of coronary artery disease in humans (adjusted for covariates and 8-year values) (aHR 1.56 (95% CI: 1.02, 2.37)).
“1.56 per 309 mg/dL-years of LDL-C (95% CI: 1.02, 2.37)”
Humansadjusted for covariates and 8-year valuesper 309 mg/dL-years8-year cumulative exposure
Low-density lipoprotein cholesterol is linked with a higher risk of coronary artery disease in humans (biomarker elevation) (HR 1.60 (95% CI: 1.48-1.66)).
Low-density lipoprotein cholesterol is linked with a higher risk of coronary artery disease in humans (UK Biobank participants) (HR 1.23, 95% CI 1.21–1.25).
“CAD was more strongly linked to low-density lipoprotein cholesterol (LDL-C; HR 1.23, 95% CI 1.21–1.25), the CAD polygenic risk score (PRS), and systolic blood pressure (SBP).”
Omega-3 fatty acids lower the risk of coronary artery disease in humans (top tertile of the expected benefit) (1.21% absolute risk reduction vs 0.47% average).
“there was 1.21% absolute CHD risk reduction in the top tertile of the expected benefit, compared with the average effect of 0.47% risk reduction.”
Human trialtop tertile of the expected benefit5-yearn = 25,871
Omega-3 fatty acids lower the risk of coronary artery disease in humans.
“According to primary informed priors, probabilities of omega-3 FA being effective versus placebo (i.e. posterior HR < 1) were 99.7% for CHD, 99.6% for total MI, 98.4% for CVD, 98.8% for all-cause death, 99.8% for cardiovascular death, and 33.7% for stroke, respectively.”
Human trial1 g per daymedian of 5.3 years (range, 3.8 to 6.1)n = 25,871
Conjugated equine estrogens with medroxyprogesterone acetate
↑upin humans1HR 1.47
1 study
Conjugated equine estrogens with medroxyprogesterone acetate raises the risk of coronary artery disease in humans among women without baseline statin use, women with an intact uterus (HR 1.47 (95% CI 1.13-1.90)).
“For CEE+MPA, there was also no difference by statin use, HR = 1.02 (95% CI: 0.55-1.89) and HR = 1.47 (95% CI: 1.13-1.90), respectively.”
Human trialamong women without baseline statin use, women with an intact uterus5 yearsfemales
Human studies associate frailty and cardiovascular biological age gap with coronary artery disease. Lipid and polygenic risk measures track disease risk, although a cohort finds no polygenic-score association in Black participants but an association in White participants with high scores; statin use associates with lower risk in high-polygenic-risk groups.
Summary rewritten as its findings changed.
As it read before
Human cohorts link higher LDL cholesterol, metabolic syndrome and frailty to coronary artery disease risk. Dietary associations differ: a healthy plant-based score relates to lower risk, whereas an overall plant-based score relates to higher incidence but lower mortality. A human trial finds no effect of screening on coronary disease in asymptomatic adults with diabetes and no known disease.
Summary rewritten as its findings changed.
As it read before
In human cohorts, coronary artery disease risk increases with elevated low-density lipoprotein cholesterol, higher triglyceride-glucose index, frailty, and prolonged mobile phone call duration. In human observational data, the disease impairs specific cognitive tasks without altering global cognition.
Heart artery disease odds were slightly higher, with an odds ratio of 1.06 per genetically predicted 19% decrease in a blood inflammation marker.Heart artery disease odds were slightly higher, with an odds ratio of 1.06 per genetically predicted 19% decrease in a blood inflammation marker.
For developing at least three heart and metabolic diseases, hazard ratios were 0.92 for high-quality carbohydrates and 1.11 for low-quality carbohydrates.For developing at least three heart and metabolic diseases, hazard ratios were 0.92 for high-quality carbohydrates and 1.11 for low-quality carbohydrates.
Who was studied177,763 UK Biobank participants without cardiometabolic diseases, median 12.56 years
What changedAt least three heart and metabolic diseases were less likely with high-quality carbohydrates (hazard ratio 0.92), more likely with low-quality carbohydrates (1.11)
The catchOther health habits among high-quality carbohydrate eaters could influence disease risk
Ideal versus poor heart health was associated with a 53% lower relative risk of cardiovascular disease in 242,951 UK Biobank participants.Ideal versus poor heart health was associated with a 53% lower relative risk of cardiovascular disease in 242,951 UK Biobank participants.